given
extens
use
antibiot
intens
care
unit
icu
nosocomi
infect
multidrugresist
mdr
pathogen
icu
becom
major
problem
previou
prospect
surveil
studi
asian
countri
resist
imipenem
observ
acinetobact
isol
pseudomona
aeruginosa
isol
mdr
rate
among
patient
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
respect
mortal
rate
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
higher
communityacquir
pneumonia
healthcareassoci
pneumonia
furthermor
mdr
pathogen
increas
mortal
rate
icuacquir
pneumonia
therefor
control
preval
mdr
pathogen
icu
mandatori
patient
safeti
effort
made
decreas
risk
mdr
pathogen
transmiss
method
activ
surveil
cultur
room
placement
cohort
hand
hygien
use
clean
glove
gown
enforc
strict
adher
precaut
use
decreas
incid
rate
ir
mdr
pathogen
infect
howev
precaut
focu
persontoperson
transmiss
import
environment
contamin
well
understood
present
studi
elucid
effect
environment
chang
reloc
medic
icu
micu
respiratori
mdr
microorgan
icu
novemb
juli
patient
admit
micu
tertiari
referr
center
seoul
nation
univers
hospit
screen
adult
patient
year
includ
remodel
center
micu
patient
move
newlybuilt
temporari
micu
march
prior
reloc
micu
open
bed
two
isol
bed
averag
space
per
patient
among
open
bed
four
belong
depart
neurolog
exclud
analysi
reloc
micu
open
bed
two
isol
bed
belong
depart
intern
medicin
averag
space
per
patient
patient
retrospect
analyz
term
baselin
demograph
sex
age
underli
comorbid
acut
physiolog
chronic
health
evalu
apach
ii
score
reloc
use
medic
potenti
effect
respiratori
microbiota
antacid
steroid
antibiot
use
also
review
clinic
outcom
compar
use
antibiot
length
micu
stay
length
hospit
stay
inhospit
mortal
day
medic
use
ventil
use
calcul
calendar
day
studi
conduct
accord
amend
declar
helsinki
approv
institut
review
board
seoul
nation
univers
hospit
protocol
requir
inform
consent
waiv
retrospect
studi
design
patient
record
inform
anonym
prior
analysi
maxim
sensit
respiratori
microbiom
detect
sever
respiratori
specimen
cultur
result
review
noninvas
respiratori
specimen
sputum
endotrach
aspir
along
invas
respiratori
specimen
bronchial
wash
bronchoalveolar
lavag
fluid
includ
sputum
collect
steril
conic
tube
cough
effort
patient
endotrach
aspir
perform
attend
nurs
steril
cathet
salin
bronchoscop
specimen
collect
boardcertifi
pulmonari
specialist
steril
bronchoscop
salin
activ
surveil
cultur
carbapenemresist
acinetobact
baumannii
crab
routin
perform
sputum
endotrach
aspir
specimen
upon
micu
admiss
also
includ
analysi
crab
methicillinresist
staphylococcu
aureu
mrsa
carbapenemresist
pseudomona
aeruginosa
crpa
extendedspectrum
esbl
produc
gramneg
enterobacteriacea
stenotrophomona
maltophilia
consid
mdr
pathogen
ir
mdr
respiratori
pathogen
compar
reloc
also
describ
monthli
microorgan
consid
micuacquir
first
detect
micu
admiss
first
appear
day
micu
stay
isol
bed
isol
wall
door
wherea
open
bed
divid
curtain
patient
nurs
ratio
day
even
night
routin
clean
floor
perform
everi
day
sodium
hypochlorit
done
frequent
visual
contamin
observ
patient
left
icu
bed
everi
surfac
patient
medic
equip
clean
benzalkonium
chlorid
medic
profession
requir
wash
hand
soap
water
chlorhexidin
glucon
ethanol
attend
patient
mdr
microorgan
detect
patient
wear
clean
nonsteril
glove
gown
obligatori
attend
patient
also
separ
item
thermomet
stethoscop
tourniquet
blood
pressur
cuff
use
adher
precaut
monitor
weekli
basi
precaut
protocol
chang
micu
reloc
categor
variabl
describ
number
percentag
compar
use
either
chisquar
test
fisher
exact
test
numer
variabl
describ
use
median
interquartil
rang
iqr
compar
use
mannwhitney
utest
ir
describ
number
per
patientday
confid
interv
ci
compar
use
poisson
regress
analys
neg
binomi
regress
analys
statist
analys
perform
use
stata
version
stata
corp
colleg
station
tx
usa
pvalu
less
consid
statist
signific
total
patient
admit
micu
studi
period
among
patient
admit
micu
reloc
admit
afterward
patient
predominantli
male
median
age
year
iqr
year
median
apach
ii
score
iqr
among
patient
diagnos
sepsi
diagnos
pneumonia
preval
sepsi
increas
significantli
micu
reloc
common
underli
comorbid
hematolog
malign
follow
solid
organ
malign
diabet
mellitu
heart
failur
endstag
renal
diseas
liver
cirrhosi
solid
organ
transplant
bronchiectasi
proport
patient
transfer
icu
differ
reloc
antacid
administ
patient
mechan
ventil
administ
patient
median
day
iqr
day
ventil
depend
ventil
use
day
observ
patient
differ
micu
reloc
vs
steroid
administ
patient
median
day
iqr
day
baselin
characterist
differ
micu
reloc
group
total
respiratori
sampl
ci
use
perform
microbiolog
analys
per
patientday
reloc
sampl
ci
use
per
patientday
reloc
differ
statist
signific
tabl
ir
mdr
respiratori
microorgan
infect
decreas
per
patientday
micu
reloc
differ
statist
signific
ir
crab
decreas
per
patientday
ir
micuacquir
crab
decreas
per
patientday
ir
mrsa
decreas
per
patientday
ir
micuacquir
mrsa
decreas
per
patientday
chang
mdr
respiratori
microorgan
includ
maltophilia
esblproduc
gramneg
enterobacteriacea
crpa
also
statist
signific
figur
patient
sepsi
pneumonia
analyz
separ
result
similar
patient
sepsi
ir
mdr
pathogen
decreas
per
patientday
ir
crab
decreas
per
patientday
lack
statist
signific
among
patient
diagnos
pneumonia
ir
similar
mdr
pathogen
stay
per
patientday
crab
decreas
without
signific
per
patientday
monthli
ir
mdr
respiratori
microorgan
specifi
assess
effect
micu
reloc
contrast
high
ir
mdr
respiratori
microorgan
februari
per
patientday
ir
march
month
reloc
micu
occur
decreas
per
patientday
ir
decreas
per
patientday
may
differ
februari
may
statist
signific
figur
howev
ir
rose
per
patientday
june
patient
diagnos
least
one
detect
mdr
pathogen
detect
rate
significantli
higher
observ
month
includ
april
patient
may
patient
high
rate
crab
patient
mrsa
patient
detect
main
factor
contribut
increas
mdr
microorgan
crab
mrsa
crpa
two
patient
esblproduc
gramneg
enterobacteriacea
two
patient
also
detect
june
review
commonli
use
antibiot
found
carbapenem
often
use
day
per
patientday
reloc
day
reloc
use
antibiot
piperacillintazobactam
vs
day
per
patientday
quinolon
vs
day
per
patientday
glycopeptid
vs
day
per
patientday
linezolid
vs
day
per
patientday
differ
significantli
accord
micu
reloc
howev
use
colistin
decreas
significantli
day
ci
day
day
ci
day
per
patientday
figur
compar
clinic
outcom
micu
reloc
among
patient
includ
studi
overal
inhospit
mortal
rate
median
length
micu
stay
day
iqr
day
median
length
hospit
stay
day
iqr
day
length
micu
stay
median
vs
day
inhospit
mortal
vs
differ
significantli
two
group
howev
length
hospit
stay
shorten
reloc
median
day
iqr
day
median
day
iqr
day
statist
signific
tabl
retrospect
singlecent
studi
reloc
micu
led
nonsignific
chang
ir
mdr
respiratori
microorgan
includ
crab
mrsa
howev
use
colistin
significantli
reduc
length
hospit
stay
shorten
first
studi
describ
import
environment
chang
infect
mdr
pathogen
includ
crab
one
respiratori
microorgan
commonli
found
icu
detect
rate
mdr
respiratori
microorgan
use
antibiot
studi
compar
report
previou
studi
prospect
studi
spain
detect
rate
mdr
respiratori
pathogen
icu
patient
pneumonia
studi
patient
least
one
detect
mdr
respiratori
microorgan
patient
pneumonia
detect
mdr
respiratori
microorgan
prospect
studi
south
korea
report
detect
rate
crab
activ
surveil
cultur
studi
crab
detect
patient
prospect
studi
china
report
mrsa
incid
case
per
icu
admiss
retrospect
studi
canada
report
mrsa
incid
case
per
patientday
studi
reveal
mrsa
case
per
admiss
case
per
patientday
use
piperacillintazobactam
glycopeptid
quinolon
similar
report
previou
studi
center
use
carbapenem
higher
thirdgener
cephalosporin
lower
previous
report
result
show
nonsignific
chang
ir
mdr
respiratori
microorgan
reloc
ir
seem
drop
right
reloc
increas
time
pass
especi
june
ir
mdr
respiratori
microorgan
highest
studi
period
mostli
crab
mrsa
although
exact
reason
sudden
outbreak
crab
mrsa
june
could
clarifi
due
studi
retrospect
design
factor
could
consid
among
patient
admit
micu
june
higher
proport
place
mechan
ventil
patient
month
patient
durat
ventil
applic
also
tend
slightli
longer
june
mean
day
month
mean
day
although
differ
statist
signific
applic
mechan
ventil
ventilatorday
previous
associ
higher
risk
mdr
acinetobact
baumannii
colon
colon
establish
next
patient
admit
environ
might
expos
elev
risk
develop
infect
especi
acinetobact
speci
furthermor
contamin
healthcar
worker
protect
gown
glove
routin
manag
patient
frequent
acinetobact
speci
mrsa
factor
could
explain
colon
rate
mdr
microorgan
increas
time
even
reloc
studi
demonstr
signific
decreas
colistin
use
despit
nonsignific
chang
ir
crab
respiratori
specimen
explain
fact
crab
common
environment
colon
acinetobact
speci
known
caus
nosocomi
infect
caus
gramneg
bacilli
therefor
possibl
signific
proport
patient
might
crab
colon
respiratori
system
rather
infect
pathogen
crab
result
decreas
use
colistin
also
found
shorten
hospit
stay
among
patient
micu
reloc
baselin
characterist
age
sex
apach
ii
score
underli
diseas
differ
significantli
reloc
differ
clinic
outcom
could
result
chang
associ
micu
reloc
includ
reduc
use
colistin
sever
retrospect
studi
report
acinetobact
baumannii
infect
associ
longer
hospit
stay
inappropri
use
antibiot
initi
day
hospitalstay
known
associ
longer
hospit
stay
inappropri
use
commonli
associ
acinetobact
speci
although
mortal
rate
differ
reloc
present
studi
contradict
report
differ
mortal
rate
accord
acinetobact
infect
inconsist
durat
hospit
mortal
rate
could
caus
low
virul
acinetobact
speci
studi
sever
limit
first
retrospect
studi
singl
center
inform
recent
antibiot
use
adequ
antibiot
use
histori
mdr
infect
could
obtain
second
difficult
discrimin
colon
pathogen
due
studi
retrospect
natur
result
must
replic
futur
prospect
studi
generaliz
clinic
set
third
due
center
train
curriculum
annual
turnov
resid
doctor
occur
march
therefor
resid
doctor
februari
nearli
year
practic
physician
wherea
march
year
practic
experi
icu
doctor
turnov
might
affect
clinic
outcom
micu
reloc
howev
number
mdr
pathogen
detect
previou
year
reveal
signific
monthli
variabl
supplementari
tabl
impli
annual
turnov
resid
might
affect
rate
mdr
pathogen
detect
fourth
environment
sampl
micu
reloc
conduct
collect
inform
futur
studi
could
support
result
conclus
ir
mdr
respiratori
microorgan
seem
decreas
micu
reloc
increas
subsequ
month
therebi
lead
nonsignific
differ
ir
reloc
nonetheless
use
colistin
use
significantli
reduc
although
differ
overal
mortal
observ
length
hospit
stay
shorten
find
emphas
import
environment
contamin
control
especi
crab
